| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 12/30/2009 | CA2729545A1 Regulated genetic suicide mechanism compositions and methods |
| 12/30/2009 | CA2729476A1 Recombinant cell producing 2-hydroxyisobutyric acid |
| 12/30/2009 | CA2729375A1 Improved protein production and storage in plants |
| 12/30/2009 | CA2729294A1 Toxin genes and methods for their use |
| 12/30/2009 | CA2729254A1 Expression vectors based on modified ribosomal protein promoters and uses thereof in post-transcriptional assessment |
| 12/30/2009 | CA2729095A1 Antibody producing non-human mammals |
| 12/30/2009 | CA2728708A1 Factor viii muteins with reduced immunogenicity |
| 12/30/2009 | CA2728142A1 System for the determination of molecules altering the function of interferon, method therefor and compounds altering interferon activity |
| 12/30/2009 | CA2728038A1 Novel immunoadjuvant flagellin-based compounds and use thereof |
| 12/30/2009 | CA2728012A1 Factor viii, von willebrand factor or complexes thereof with prolonged in vivo half-life |
| 12/30/2009 | CA2728004A1 Humanization of rabbit antibodies using a universal antibody framework |
| 12/30/2009 | CA2727992A1 Stable and soluble antibodies inhibiting tnfa |
| 12/30/2009 | CA2727894A1 Recombinant cells and plants for synthesis of very long chains fatty acid (vlcfa) |
| 12/30/2009 | CA2727310A1 Plants having enhanced yield-related traits and a method for making the same |
| 12/30/2009 | CA2726894A1 Therapeutic agents comprising elastin-like peptides |
| 12/30/2009 | CA2726465A1 Meningococcal multivalent native outer membrane vesicle vaccine, methods of making and use thereof |
| 12/30/2009 | CA2726054A1 Method of producing yeast biomass |
| 12/30/2009 | CA2695590A1 Method of efficiently establishing induced pluripotent stem cells |
| 12/29/2009 | US7640114 Method of diagnosis of cancer based on gene expression profiles in cells |
| 12/29/2009 | US7638694 Plants and seeds of hybrid corn variety CH944969 |
| 12/29/2009 | US7638693 Plants and seeds of hybrid corn variety CH120555 |
| 12/29/2009 | US7638692 Plants and seeds of hybrid corn variety CH538026 |
| 12/29/2009 | US7638688 Maize hybrid variety X5M895 |
| 12/29/2009 | US7638687 Cotton cultivar PM 3535 BG/RR |
| 12/29/2009 | US7638686 Cotton cultivar DP 174 RF |
| 12/29/2009 | US7638685 Cotton cultivar DP 141 B2RF |
| 12/29/2009 | US7638684 Cotton cultivar 06W650F |
| 12/29/2009 | US7638683 Cotton cultivar DP 121 RF |
| 12/29/2009 | US7638682 Soybean cultivar HFPR-5 |
| 12/29/2009 | US7638681 Auxin transport proteins |
| 12/29/2009 | US7638680 Methods for stabilizing and controlling apomixis |
| 12/29/2009 | US7638679 Screening for agents that modulate tolerance to an immunogen; delivering a nucleic acid that directs expression of the immunogen to the liver of an animal, resulting in sustained expression of the immunogen in the liver. |
| 12/29/2009 | US7638678 Transgenic mammals with partial depletion of ovarian follicles and/or induced menopausal syndromes; veterinary medicine; diagnosis, prevention and treatment of bone, nervous system and cardiovascular disorders; contraceptives |
| 12/29/2009 | US7638622 Short interfering RNA sequences for use as therapeutic tools in treatment of cancer, diabetes and nervous system disorders |
| 12/29/2009 | US7638621 Radionally designed siRNA; duplex region comprises a sense region and an antisense region |
| 12/29/2009 | US7638620 Use to enhance apoptosis; antiproliferative agents |
| 12/29/2009 | US7638619 Nucleotide sequences coding hepatocyte specific immunoglobulin for use in prevention and treatment of cell proliferative disorders; immunotherapy; antitumor agents |
| 12/29/2009 | US7638618 Nucleic acids encoding a hirudin and pro-insulin as superscretable peptides and for parallel improvement of the exported forms of one or more polypeptides of interest |
| 12/29/2009 | US7638615 Fluorescent proteins and methods for using same |
| 12/29/2009 | US7638614 Xenobiotic related induction of gene expression |
| 12/29/2009 | US7638613 For use in the treatment of paper pulp, stable over wide temperature and pH range |
| 12/29/2009 | US7638612 Compositions and methods for cDNA synthesis |
| 12/29/2009 | US7638607 Urocortin proteins and uses thereof |
| 12/29/2009 | US7638605 Fully human antibodies directed against the human insulin-like growth factor-1 receptor |
| 12/29/2009 | US7638602 Heterodimeric human cytokine receptor comprising Zcytor16/Zcytor11 components for use in treatment of cell proliferative, inflammatory and immune disorders |
| 12/29/2009 | US7638601 Transient receptor potential channel TRPM8 and its use |
| 12/29/2009 | US7638599 Enhance uptake of a pharmaceutically active agent into a cell, into or out of an intracellular compartment, and across a cell layer either directly or from a pharmaceutically active agent loaded particle; drug delivery |
| 12/29/2009 | US7638499 Hepatitis C virus codon optimized non-structural NS3/4A fusion gene |
| 12/29/2009 | US7638498 Substances for preventing and treating autoimmune diseases |
| 12/29/2009 | US7638497 For enhancing apoptosis and treating proliferative disorders; antitumor agents |
| 12/29/2009 | US7638492 Using programmed death-1 (PD-1) protein as evaluative tool to identify modulators for treatment and prevention of nervous system, autoimmune, cell proliferative and allergic disorders |
| 12/29/2009 | US7638490 For treating anorexia or cachexia |
| 12/29/2009 | US7638482 Protein kinase C zeta as a drug target for arthritis and other inflammatory diseases |
| 12/29/2009 | US7638480 Use of osteoprotegerin for the treatment and/or prevention of fibrotic disease |
| 12/29/2009 | US7638334 Method for generating engineered cells by homologously recombining segments having increased degeneracy |
| 12/29/2009 | US7638333 Anthrax vaccine |
| 12/29/2009 | US7638332 Low pressure gas accelerated gene gun |
| 12/29/2009 | US7638331 chimeric gene construct composed of a COX-2 promoter operably linked to at least one apoptosis-inducing gene that can cause selectively induced apoptosis in a population of diseased cells; entire classes of cells can be treated with one transfection |
| 12/29/2009 | US7638327 polypeptides related to a receptor to BAFF (a B-cell activating factor belonging to the Tumor Necrosis Factor family, which is associated with expression of B-cells and immunoglobulins); treatment of cancers, lymphomas, autoimmune diseases related to B-cells |
| 12/29/2009 | US7638326 Activation and expansion of T-cells using an engineered multivalent signaling platform |
| 12/29/2009 | US7638325 Microarray for activation and or stimulation of lymphocytes; immunotherapy; anticarcinogenic agents; viricides; bactericides; fungicides |
| 12/29/2009 | US7638323 for treating or preventing hyperacute rejection; solid phase synthesis; genetic engineering |
| 12/29/2009 | US7638322 vascular endothelial growth factor (VEGF); ischemic heart disease |
| 12/29/2009 | US7638318 RNA picornavirus; selectively kills some types of tumors; making new oncolytic virus derivatives and of altering viruses to have tumor-specific tropisms |
| 12/29/2009 | US7638317 improved polypeptides by substituting or deleting specified amino acids in fungal lipolytic enzymes; reduction of dough stickiness when they are added to a dough |
| 12/29/2009 | US7638316 Culturing cell comprising exogenous nucleic acid molecule encoding polypeptide capable of producing 3-hydroxypropionic acid from phosphoenolpyruvate (PEP), pyruvate, or lactate |
| 12/29/2009 | US7638315 Nucleic acid with beta-keto acyl-ACP synthase (KS) activity, chain length factor (CLF) activity, acyl transferase (AT) activity, and enoyl ACP-reductase (ER) activity; biosynthesis of polyunsaturated fatty acids (PUFAs) |
| 12/29/2009 | US7638311 using branching enzyme from a bacterium of the genus Neisseria; for use in pharmaceutical/cosmetic industries |
| 12/29/2009 | US7638305 Produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins; has anti-hepatitis activity; culturing |
| 12/29/2009 | US7638303 Soluble ErbB3 receptor isoforms |
| 12/29/2009 | US7638302 Soluble ErbB3 receptor isoforms |
| 12/29/2009 | US7638300 In vivo incorporation of unnatural amino acids |
| 12/29/2009 | US7638298 Method for detecting mutation and a method for inducing mutation |
| 12/29/2009 | US7638296 culturing in a medium containing insulin; use in the treatment of anemia; industrial scale production; high quality, purity |
| 12/29/2009 | US7638289 Human T2R55 taste receptor and related assays for identifying human bitter taste modulators |
| 12/29/2009 | US7638288 Methods for inducing differentiation of undifferentiated mammalian cells into osteoblasts |
| 12/29/2009 | US7638286 producing an antibody by inoculating an animal with a polypeptide; monoclonal antibody specifically binds to a zalpha11 polypeptide; treating blood disorders |
| 12/29/2009 | US7638283 Amyloid β protein (globular assembly and uses thereof) |
| 12/29/2009 | US7638282 Genes of an otitis media isolate of nontypeable Haemophilus influenzae |
| 12/29/2009 | US7638281 Polypeptide, cDNA encoding the same and use of them |
| 12/29/2009 | US7638279 Preferential nucleotide sequences for use in in the detection, quantitation and/or analysis of nucleic acids |
| 12/29/2009 | US7638276 Using encapuslated gene sequences as tools for directed evolution of nucleic acids; microencapsulation and gene expression |
| 12/29/2009 | US7638269 Viral capsid assembly intermediates and methods of production |
| 12/29/2009 | US7638141 Generating multipotent cells from sstem cells isolated from residual cord blood; tissue engineering and regenerative medicine |
| 12/29/2009 | US7638136 fusion proteins; encode hyperimmune serum reactive antigen or fragment thereof; immunogens |
| 12/29/2009 | US7638134 Insertion sites in fowlpox vectors |
| 12/29/2009 | US7638133 transformed with an expression vector that has a polynucleotide encoding a foreign antigenic protein, wherein the polynucleotide is a modified one in which the third position of each codon is substituted with G or C without a change of an amino acid; against human immunodeficiency virus infection |
| 12/29/2009 | US7638132 genetically stable vaccinia viruses and vaccinia virus vectors with higher safety, which undergo reversion with difficulty because of the removal of a gene involved in reversion from an attenuated smallpox vaccinia virus LC16m8 strain or its parental LC16mO strain, which tends to undergo reverse mutation |
| 12/29/2009 | US7638131 Coccidiosis poultry vaccine |
| 12/29/2009 | US7638129 Monomer protein with bone morphogenetic activity and medicinal agent containing the same for preventing and treating diseases of cartilage and bone |
| 12/29/2009 | US7638120 High transgene expression of a pseudotyped adeno-associated virus type |
| 12/29/2009 | US7638119 Method of diminishing the symptoms of neurodegenerative disease |
| 12/29/2009 | US7638115 Methods and compositions for the introduction of molecules into cells |
| 12/29/2009 | CA2425663C Fluorescent nucleobase conjugates having anionic linkers |
| 12/29/2009 | CA2338543C Method of direct identification of compound efficacy at a g protein-coupled orphan receptor |
| 12/29/2009 | CA2331783C Chemically modified proteins with a carbohydrate moiety |
| 12/29/2009 | CA2302385C Gene encoding .alpha.-subunit of rice anthranilate synthase and dna relating thereto |
| 12/29/2009 | CA2263726C Transgenic plants expressing cellulolytic enzymes |
| 12/29/2009 | CA2201885C Dna polymerases having modified nucleotide binding site for dna sequencing |
| 12/29/2009 | CA2189848C Photocleavable agents and conjugates for the detection and isolation of biomolecules |